Hepatitis C virus infection epidemiology among people who inject drugs in Europe: A systematic review of data for scaling up treatment and prevention

L. WIESSING ; M. FERRI ; B. GRADY ; M. KANTZANOU ; I. SPERLE ; K. J. CULLEN ; EMCDDA DRID Group ; A. HATZAKIS ; M. PRINS ; P. VICKERMAN ; J. V. LAZARUS ; V. D. HOPE ; C. MATHEI | 2014
Dans PLOS ONE (Vol.9, n°7, July 2014) Article : Périodique

Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in the literature of informati[...]

Plus d'info

Ajouter à la sélection

Lien externe

Pilot study: Combining formal and peer education with FibroScan to increase HCV screening and treatment in persons who use drugs

A. ARAIN ; J. DE SOUSA ; K. CORTEN ; R. VERRANDO ; H. THIJS ; C. MATHEI ; F. BUNTINX ; G. ROBAEYS | 2016
Dans Journal of Substance Abuse Treatment (Vol.67, August 2016) Article : Périodique

Background: Treatment uptake for hepatitis C virus (HCV) infection remains low in persons who inject drugs (PWID), due to lack of knowledge and low perceived need for treatment. Therefore, we conducted a pilot study to assess the influence on kn[...]

Plus d'info

Ajouter à la sélection

The epidemiology of hepatitis C among injecting drug users in Belgium

C. MATHEI ; G. ROBAEYS ; VAN RANST M. ; P. VAN DAMME ; BUNTINX F. | 2005
Périodique

ENGLISH : In industrialised countries, injecting drug use is currently the most important risk factor for infection with hepatitis C, resulting in high prevalence rates of hepatitis C among injecting drug users. To contain the hepatitis C epid[...]

Plus d'info

Ajouter à la sélection